Urinary tract colonization is enhanced by a plasmid that regulates uropathogenic Acinetobacter baumannii chromosomal genes

Abstract

Multidrug resistant (MDR) Acinetobacter baumannii poses a growing threat to global health. Research on Acinetobacter pathogenesis has primarily focused on pneumonia and bloodstream infections, even though one in five A. baumannii strains are isolated from urinary sites. In this study, we highlight the role of A. baumannii as a uropathogen. We develop the first A. baumannii catheter-associated urinary tract infection (CAUTI) murine model using UPAB1, a recent MDR urinary isolate. UPAB1 carries the plasmid pAB5, a member of the family of large conjugative plasmids that represses the type VI secretion system (T6SS) in multiple Acinetobacter strains. pAB5 confers niche specificity, as its carriage improves UPAB1 survival in a CAUTI model and decreases virulence in a pneumonia model. Comparative proteomic and transcriptomic analyses show that pAB5 regulates the expression of multiple chromosomally-encoded virulence factors besides T6SS. Our results demonstrate that plasmids can impact bacterial infections by controlling the expression of chromosomal genes.

References 82

1. 1.
   Hijacking host cell highways: manipulation of the host actin cytoskeleton by obligate intracellular bacterial pathogens · 2016

   Not checked
2. 2.

   Brady AM, et al. Low invasiveness of pneumococcal serotype 11A is linked to Ficolin-2 recognition of O-acetylated capsule epitopes and lectin complement pathway activation. J. Infect. Dis. 2014;210:1155-1165.

   Not in our library10.1093/infdis/jiu195

3. 3.
   Colonizing opportunistic pathogens (COPs): The beasts in all of us. · 2017

   Not checked
4. 4.

   Fishman JA. Opportunistic Infections-Coming to the Limits of Immunosuppression? Cold Spring Harb. Perspect. Med. 2013;3:a015669-a015669.

   Not in our library10.1101/cshperspect.a015669

5. 5.

   Weiner LM, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011–2014. Infect. Control Hosp. Epidemiol. 2016;37:1288-1301.

   Not in our library10.1017/ice.2016.174

6. 6.

   Dexter C, Murray GL, Paulsen IT, Peleg AY. Community-acquired Acinetobacter baumannii: clinical characteristics, epidemiology and pathogenesis. Expert Rev. Anti. Infect. Ther. 2015;13:567-573.

   Not in our library10.1586/14787210.2015.1025055

7. 7.
   Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial · 2017

   No notice
8. 8.

   Tacconelli, E., Magrini, N., Kahlmeter, G. & Singh, N. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. WHO Publication, 1, 1–7 (2017).

   Not in our library

9. 9.

   Hugh R, Reese R. Designation of the type strain for Bacterium anitratum Schaub and Hauber 1948. Int. J. Syst. Bacteriol. 1967;17:245-254.

   Not in our library10.1099/00207713-17-3-245

10. 10.

    Piechaud M, Second L. Studies of 26 strains of Moraxella Iwoffi. Ann. Inst. Pasteur. 1951;80:97-9.

    Not in our library

11. 11.

    Wang N, Ozer EA, Mandel MJ, Hauser AR. Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung. MBio. 2014;5:1-8.

    Not in our library10.3391/mbi.2014.5.1.01

12. 12.

    Gaddy JA, et al. Role of Acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect. Immun. 2012;80:1015-1024.

    Not in our library10.1128/iai.06279-11

13. 13.

    Kinsella Rachel L., Lopez Juvenal, Palmer Lauren D., Salinas Nichole D., Skaar Eric P., Tolia Niraj H., Feldman Mario F. Defining the interaction of the protease CpaA with its type II secretion chaperone CpaB and its contribution to virulence inAcinetobacterspecies. Journal of Biological Chemistry. 2017;292(48):19628-19638.

    Not in our library10.1074/jbc.m117.808394

14. 14.

    Jacobs AC, et al. AB5075, a highly virulent isolate of Acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. MBio. 2014;5:1-10.

    Not in our library10.1128/mbio.01076-14

15. 15.

    Harris G, et al. A Mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain. Antimicrob. Agents Chemother. 2013;57:3601-3613.

    Not in our library10.1128/aac.00944-13

16. 16.

    Noto MJ, Becker KW, Boyd KL, Schmidt AM, Skaar EP. RaGE-mediated suppression of interleukin-10 results in enhanced mortality in a murine model of Acinetobacter baumannii sepsis. Infect. Immun. 2017;85:1-9.

    Not in our library10.1128/iai.00954-16

17. 17.

    Russo TA, et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect. Immun. 2010;78:3993-4000.

    Not in our library10.1128/iai.00366-10

18. 18.

    Kumar S, et al. Prospective surveillance of device-associated health care–associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India. Am. J. Infect. Control. 2018;46:202-206.

    Not in our library10.1016/j.ajic.2017.08.037

19. 19.

    Ding, R., Li, X., Zhang, X., Zhang, Z. & Ma, X. The epidemiology of symptomatic catheter-associated urinary tract infections in the intensive care unit: a 4-year single center retrospective study. Urol. J. 10.22037/uj.v0i0.4256 (2018).

    Not in our library10.22037/uj.v0i0.4256

20. 20.

    Jiménez-Guerra Gemma, Heras-Cañas Victor, Gutiérrez-Soto Miguel, del Pilar Aznarte-Padial María, Expósito-Ruiz Manuela, Navarro-Marí José María, Gutiérrez-Fernández José. Urinary tract infection by Acinetobacter baumannii and Pseudomonas aeruginosa: evolution of antimicrobial resistance and therapeutic alternatives. Journal of Medical Microbiology. 2018;67(6):790-797.

    Not in our library10.1099/jmm.0.000742

21. 21.

    Walker JN, et al. Catheterization alters bladder ecology to potentiate Staphylococcus aureus infection of the urinary tract. Proc. Natl Acad. Sci. USA. 2017;114:E8721-E8730.

    Not in our library10.1073/pnas.1707572114

22. 22.

    Xu W, et al. Host and bacterial proteases influence biofilm formation and virulence in a murine model of enterococcal catheter-associated urinary tract infection. npj Biofilms Micro. 2017;3:28.

    Not in our library10.1038/s41522-017-0036-z

23. 23.

    Mortensen BL, Skaar EP. Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection. Cell. Microbiol. 2012;14:1336-1344.

    Not in our library10.1111/j.1462-5822.2012.01817.x

24. 24.

    Flores-Mireles AL, et al. Fibrinogen release and deposition on urinary catheters placed during urological procedures. J. Urol. 2016;196:416-421.

    Not in our library10.1016/j.juro.2016.01.100

25. 25.

    Conover MS, et al. Metabolic requirements of Escherichia coli in intracellular bacterial communities during urinary tract infection pathogenesis. MBio. 2016;7:e00104-16.

    Not in our library10.1128/mbio.00104-16

26. 26.

    Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015;13:269-284.

    Not in our library10.1038/nrmicro3432

27. 27.

    Flores-Mireles AL, Pinkner JS, Caparon MG, Hultgren SJ. EbpA vaccine antibodies block binding of Enterococcus faecalis to fibrinogen to prevent catheter-associated bladder infection in mice. Sci. Transl. Med. 2014;6:254ra127-254ra127.

    Not in our library10.1126/scitranslmed.3009384

28. 28.

    Greene SE, Hibbing ME, Janetka J, Chen SL, Hultgren SJ. Human urine decreases function and expression of type 1 Pili in uropathogenic Escherichia coli. MBio. 2015;6:e00820-15.

    Not in our library10.1128/mbio.00820-15

29. 29.

    Wood CR, Ohneck EJ, Edelmann RE, Actis LA. A light-regulated type I pilus contributes to Acinetobacter baumannii biofilm, motility and virulence functions. Infect. Immun. 2018;86:e00442-18.

    Not in our library10.1128/iai.00442-18

30. 30.

    Weber BS, Ly PM, Irwin JN, Pukatzki S, Feldman MF. A multidrug resistance plasmid contains the molecular switch for type VI secretion in Acinetobacter baumannii. Proc. Natl Acad. Sci. USA. 2015;112:9442-7.

    Not in our library10.1073/pnas.1502966112

31. 31.

    Di Venanzio G, et al. Multidrug-resistant plasmids repress chromosomally encoded T6SS to enable their dissemination. Proc. Natl Acad. Sci. USA. 2019;116:1378-1383.

    Not in our library10.1073/pnas.1812557116

32. 32.

    Rivas AJ, Vences A, Husmann M, Lemos ML, Osorio CR. Photobacterium damselae subsp. damselae Major Virulence Factors Dly, Plasmid-Encoded HlyA, and Chromosome-Encoded HlyA Are Secreted via the Type II Secretion System. Infect. Immun. 2015;83:1246-1256.

    Not in our library10.1128/iai.02608-14

33. 33.

    Pilla G, McVicker G, Tang CM. Genetic plasticity of the Shigella virulence plasmid is mediated by intra- and inter-molecular events between insertion sequences. PLOS Genet. 2017;13:e1007014.

    Not in our library10.1371/journal.pgen.1007014

34. 34.

    Harding CM, et al. Pathogenic Acinetobacter species have a functional type I secretion system and contact-dependent inhibition systems. J. Biol. Chem. 2017;292:9075-9087.

    Not in our library10.1074/jbc.m117.781575

35. 35.

    Choi AHK, Slamti L, Avci FY, Pier GB, Maira-Litrán T. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J. Bacteriol. 2009;191:5953-63.

    Not in our library10.1128/jb.00647-09

36. 36.

    Justice SS, Hunstad DA, Seed PC, Hultgren SJ. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proc. Natl Acad. Sci. USA. 2006;103:19884-9.

    Not in our library10.1073/pnas.0606329104

37. 37.

    Ye L, Zheng X, Zheng H. Effect of sypQ gene on poly-N-acetylglucosamine biosynthesis in Vibrio parahaemolyticus and its role in infection process. Glycobiology. 2014;24:351-358.

    Not in our library10.1093/glycob/cwu001

38. 38.

    Ferreirinha P, et al. Poly- N -Acetylglucosamine Production by Staphylococcus epidermidis cells increases their in vivo proinflammatory effect. Infect. Immun. 2016;84:2933-2943.

    Not in our library10.1128/iai.00290-16

39. 39.

    Bentancor LV, O’Malley JM, Bozkurt-Guzel C, Pier GB, Maira-Litrán T. Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect. Immun. 2012;80:651-6.

    Not in our library10.1128/iai.05653-11

40. 40.

    Pinkner JS, et al. Rationally designed small compounds inhibit pilus biogenesis in uropathogenic bacteria. Proc. Natl Acad. Sci. USA. 2006;103:17897-17902.

    Not in our library10.1073/pnas.0606795103

Cited by papers we hold 2

• Genomic and phenotypic analyses of multidrug-resistant Acinetobacter baumannii NCCP 16007 isolated from a patient with a urinary tract infection · 2021
  Not checked
• Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.